Pasithea Therapeutics to Present at the NobleCon18 Investor Conference 2022
15 April 2022 - 6:15AM
Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the
“Company”), a novel biotechnology company focused on the research
and discovery of new and effective treatments for psychiatric and
neurological disorders, today announced its Chief Executive
Officer, Tiago Reis Marques, will present at NobleCon18 - Noble
Capital Markets’ Eighteenth Annual Investor Conference in
Hollywood, FL, as follows:
Date: |
Thursday,
April 21, 2022 |
Time: |
12:30 p.m. ET |
About Pasithea Therapeutics Corp.Pasithea
Therapeutics Corporation is a U.S. biotechnology company focused on
the research and discovery of new and effective treatments for
psychiatric and neurological disorders. With an experienced team of
experts in the fields of neuroscience and psychopharmacology,
Pasithea is developing new molecular entities for the treatment of
psychiatric and neurological disorders. Pasithea is also focused on
addressing the needs of patients currently suffering with mental
illness by providing access to IV ketamine infusions both in
clinics and in-home settings.
Pasithea Therapeutics Corp. Company
ContactDr. Tiago Reis MarquesChief Executive OfficerE:
tiago@pasithea.com
Pasithea Therapeutics Corp. Investor
RelationsLisa M. WilsonIn-Site Communications, Inc.T:
212-452-2793E: lwilson@insitecony.com
Pasithea Therapeutics (NASDAQ:KTTAW)
Historical Stock Chart
From Jun 2024 to Jul 2024
Pasithea Therapeutics (NASDAQ:KTTAW)
Historical Stock Chart
From Jul 2023 to Jul 2024